BeStock  
Markets › Compare › FDMT vs SLDB

FDMT vs SLDB

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
FDMT · 4D Molecular Therapeutics$12.59 ▲ 0.24%
SLDB · Solid Biosciences$6.85 ▼ 1.01%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

5586118150182Oct 9, '25Apr 9, '26Oct 7, '26
  • FDMT +31.7%
  • SLDB +7.0%

Head to head

MetricFDMTSLDB
Price$12.59$6.85
Change today▲ 0.24%▼ 1.01%
Market cap$695.52M$734.49M
Return, 3 months-2.3%-38.5%
Return, year to date+67.9%+21.5%
Return, 1 year+30.3%+8.6%
P/E (TTM)-4.8-3.6
P/B1.72.0
P/E percentile vs own 5y38th9th
Dividend yield––
Revenue growth (YoY, latest qtr)+25,106.7%–
Net profit growth (YoY)-33.4%-38.8%
Gross margin––
Operating margin-214.2%–
Net margin-194.7%–
Return on equity-43.3%-65.5%
Analyst target vs. price+141.7%+177.4%
Analyst buy share89%100%
RSI (14)3631
30-day volatility49.1%56.6%
Max drawdown, 1 year-41.4%-38.6%
Trend readLeaning bearishStrong downtrend
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • SLDB is the largest of the group by market value.
  • FDMT has returned the most over the past year.
  • FDMT carries the lowest trailing P/E.
  • FDMT has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top